Changeflow GovPing Healthcare & Life Sciences AtriCure Ablation Device Patent US12605202B2
Routine Notice Added Final

AtriCure Ablation Device Patent US12605202B2

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted patent US12605202B2 to AtriCure, Inc. on April 21, 2026, covering devices and accessories for percutaneous endoscopic access and ablation systems. The patent application was filed on July 16, 2024 under application number 18773970, with 9 claims granted. The technology relates to methods and devices for accessing and therapeutically treating tissue areas using minimally invasive or open surgical procedures.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO issued patent US12605202B2 to AtriCure, Inc. for ablation devices and accessories designed for percutaneous endoscopic access and tissue treatment. The patent covers technology suitable for minimally invasive surgery and open surgical procedures. Medical device companies developing similar ablation or tissue access systems should conduct freedom-to-operate analyses to confirm they do not infringe on this newly granted patent.

Patent grants do not impose compliance obligations on third parties but establish intellectual property rights that may affect competitive product development strategies. Competitors entering the cardiac or tissue ablation market should review this patent alongside existing IP landscapes.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Device and accessories for a percutaneous endoscopic access and ablation systems

Grant US12605202B2 Kind: B2 Apr 21, 2026

Assignee

AtriCure, Inc.

Inventors

Jeremy Dando, Jason Quill, Ram Kumar, Tamer Ibrahim, Guy Vanney, Al Mclevish, Aaron Owens

Abstract

Devices, systems, and methods for therapeutically treating tissue. The devices and methods are suitable for minimally invasive surgery or open surgical procedures. More particularly, methods and devices described herein permit accessing and/or treating areas of tissue with a therapeutic device.

CPC Classifications

A61B 14/1492 A61B 34/20 A61B 2034/105 A61B 2017/320069 A61B 18/24 A61B 2017/00323 A61B 2018/00577 A61B 2018/00839 A61B 2018/0212 A61B 2018/1435 A61B 2018/1861 A61B 2218/002 A61M 25/0082 A61M 25/0136 A61M 25/09

Filing Date

2024-07-16

Application No.

18773970

Claims

9

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent granting Medical device technology
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!